Clinical Trial Update: FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for FaR-RMS, an overarching Phase 1/2 study in children and adults with frontline and relapsed rhabdomyosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhabdomyosarcoma

Snippet

Sponsor: University of Birmingham | Conditions: Rhabdomyosarcoma | Phase 1, Phase 2 | Status: RECRUITING